BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11583976)

  • 1. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.
    Oka T; Yoshino T; Hayashi K; Ohara N; Nakanishi T; Yamaai Y; Hiraki A; Sogawa CA; Kondo E; Teramoto N; Takahashi K; Tsuchiyama J; Akagi T
    Am J Pathol; 2001 Oct; 159(4):1495-505. PubMed ID: 11583976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent progress in the protein-tyrosine phosphatase SHP1 gene: the significant correlation of the SHP1 gene silencing with the onset of lymphomas/leukemias].
    Oka T; Ouchida M
    Nihon Rinsho; 2003 Nov; 61(11):2025-32. PubMed ID: 14619449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
    Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
    Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas.
    Oka T; Ouchida M; Koyama M; Ogama Y; Takada S; Nakatani Y; Tanaka T; Yoshino T; Hayashi K; Ohara N; Kondo E; Takahashi K; Tsuchiyama J; Tanimoto M; Shimizu K; Akagi T
    Cancer Res; 2002 Nov; 62(22):6390-4. PubMed ID: 12438221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the monocyte-specific esterase (MSE) gene.
    Uphoff CC; Hu ZB; Gignac SM; Ma W; Rainey FA; Kreutz M; Ludwig WD; Drexler HG
    Leukemia; 1994 Sep; 8(9):1510-26. PubMed ID: 8090031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression profile of nasal NK/T cell lymphoma by cDNA microarray].
    Wang WH; Li YX; Lin C; Liu XF; Yu ZH; Song YW; Zhang XY; Fu M; Jin J; Wang SL; Liu YP
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):518-22. PubMed ID: 17147117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation.
    Koyama M; Oka T; Ouchida M; Nakatani Y; Nishiuchi R; Yoshino T; Hayashi K; Akagi T; Seino Y
    Lab Invest; 2003 Dec; 83(12):1849-58. PubMed ID: 14691303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
    Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
    Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
    Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
    Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
    Iqbal J; Weisenburger DD; Chowdhury A; Tsai MY; Srivastava G; Greiner TC; Kucuk C; Deffenbacher K; Vose J; Smith L; Au WY; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Ko YH; Sng I; Liu X; Loughran TP; Armitage J; Chan WC;
    Leukemia; 2011 Feb; 25(2):348-58. PubMed ID: 21052088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential methylation of genes that regulate cytokine signaling in lymphoid and hematopoietic tumors.
    Reddy J; Shivapurkar N; Takahashi T; Parikh G; Stastny V; Echebiri C; Crumrine K; Zöchbauer-Müller S; Drach J; Zheng Y; Feng Z; Kroft SH; McKenna RW; Gazdar AF
    Oncogene; 2005 Jan; 24(4):732-6. PubMed ID: 15580314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of FOXP3 mRNA expression in leukemia and transformed cell lines.
    Yamamoto M; Tsuji-Takayama K; Suzuki M; Harashima A; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Leuk Res; 2008 Apr; 32(4):651-8. PubMed ID: 17920118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of homeobox genes in leukemia/lymphoma cell lines.
    Nagel S; Drexler HG
    Methods Mol Biol; 2011; 731():371-80. PubMed ID: 21516422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified.
    Ishida T; Inagaki H; Utsunomiya A; Takatsuka Y; Komatsu H; Iida S; Takeuchi G; Eimoto T; Nakamura S; Ueda R
    Clin Cancer Res; 2004 Aug; 10(16):5494-500. PubMed ID: 15328188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription and protein expression of mb-1 and B29 genes in human hematopoietic malignancies and cell lines.
    Verschuren MC; Comans-Bitter WM; Kapteijn CA; Mason DY; Brouns GS; Borst J; Drexler HG; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):1939-47. PubMed ID: 8255092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.